Filing Details

Accession Number:
0001127602-17-015266
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-21 16:04:41
Reporting Period:
2017-04-19
Filing Date:
2017-04-21
Accepted Time:
2017-04-21 16:04:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859737 Hologic Inc HOLX X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042902449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346770 M Lawrence Levy 250 Campus Drive
Marlborough MA 01752
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-04-19 1,500 $42.44 25,839 No 4 S Direct
Common Stock Acquisiton 2017-04-19 9,336 $32.82 35,175 No 4 M Direct
Common Stock Disposition 2017-04-19 9,336 $42.50 25,839 No 4 S Direct
Common Stock Acquisiton 2017-04-20 2,664 $32.82 28,503 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2017-04-19 9,336 $0.00 9,336 $32.82
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2017-04-20 2,664 $0.00 2,664 $32.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,664 2008-01-01 2017-10-22 No 4 M Direct
76,000 2008-01-01 2017-10-22 No 4 M Direct
Footnotes
  1. Transaction pursuant to an existing Rule 10b5-1 trading plan.
  2. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $42.36 to $42.59 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  3. Includes 2,427 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan.